Current Studies

CANM cardiologists are currently engaged in a diverse assortment of clinical studies investigating new approaches to preventing and treating cardiovascular conditions and diseases. As a result, we are able to offer innovative treatment options and the very latest therapies to our patients.

CHAMPION
A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects who Require Percutaneous Coronary Intervention. More >>
CURRENT
Randomized, Multinational, Double-blind Study Comparing a High Loading Dose Regimen of Clopidogrel versus Standard Dose in Patients with Unstable Angina or Non-ST Segment Elevation Myocardial Infarction Managed with an Early Invasive Strategy. More >>
IMPROVE-IT
A Multicenter, Double-blind, Randomized Study to Establish the Clinical Benefit and Safety ofVytorin (ezetimibe/simvastatin) versus Simvastatin Monotherapy in Highrisk Patients Presenting with Acute Coronary Syndrome . More >>
INSPIRE ME
International Study of Prediction ofIntra-Abdominal Adiposity and its Relationships with Cardiometabolic Risk/Intra-Abdominal Adiposity. More >>
MADIT
Multicenter Automatic Defibrillator Implantation Cardiac Resynchronization Therapy Trial. More >>
ACCESS
Patent Foramen Ovale Closure with the Amplatzer PFO Occluder in Patients with Recurrent Cryptogenic Stroke due to Presumed Paradoxical Embolism through a Patent Foramen Ovale who have Failed Conventional Drug Therapy. More >>
PROSPECT
Providing Regional Observations to Study Predictors of Events in the Coronary Tree - An Imaging Study in Patients with Unstable Atherosclerotic Lesions. More >>
RATE
Registry of AT/AF Episodes in the CRM Device Population . More >>
RELY
Randomized Evaluation of Long-term Anticoagulant Therapy Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open-label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation: Prospective, Multicenter, Parallel-group, Non-inferiority Trial . More >>
REDUCE HF
Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients with Chronic Heart Failure . More >>
REVERSE
Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction . More >>
Roche M & M
A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of R04607381 on Cardiovascular (CV) Risk in Stable Coronary Heart Disease Patients with a Documented Recent Acute Coronary Syndrome (ACS) . More >>
ROCKET AF
A Prospective, Randomized, Double-blind, Double-dummy, Parallel-group, Multicenter, Event-driven, Non-inferiority Study Comparing the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY 59-7939) with Adjusted-dose Oral Warfarin for the Prevention of Stroke and Non-central Nervous System Systemic Embolism in Subjects with Non-valvular Atrial Fibrillation . More >>
SPIRIT III
A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects with De Novo Native Coronary Artery Lesions . More >>
TAXUS ATLAS
A Multicenter, Single-arm Study of the TAXUS Liberte'-SR Stent for the Treatment of Patients with De Novo Coronary Artery Lesions . More >>
TAXUS ATLAS LONG LESION
A Multicenter, Single-arm Study of the Taxus Liberte'SR Stent for the Treatment of Patients with Long De Novo Coronary Artery Lesions. More >>
TAXUS ATLAS SMALL VESSEL
A Multicenter, Single-arm Study of the Taxus Liberte'-SR Stent for the Treatment of Patients with De Novo Coronary Artery Lesion in Small Vessels . More >>
Tele-HF
Telemonitoring to Improve Heart Failure Outcomes . More >>
TRA2P
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist for Secondary Prevention of Atherothrombotic Ischemic Events . More >>
XIENCE V
Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study . More >>